Compound 1491
Identifiers
- Canonical SMILES:
Cc1cc2c(CCc3ccccc3)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(CCc3ccccc3)c(O)c(O)cc2c1O
- IUPAC name:
3-methyl-5-(2-phenylethyl)-2-[1,6,7-trihydroxy-3-methyl-5-(2-phenylethyl)naphthalen-2-yl]naphthalene-1,6,7-triol
- InChi:
InChI=1S/C38H34O6/c1-21-17-27-25(15-13-23-9-5-3-6-10-23)35(41)31(39)19-29(27)37(43)33(21)34-22(2)18-28-26(16-14-24-11-7-4-8-12-24)36(42)32(40)20-30(28)38(34)44/h3-12,17-20,39-44H,13-16H2,1-2H3
- InChiKey:
BGXPXERSQBZILH-UHFFFAOYSA-N
External links
![]() 44191815 |
![]() CHEMBL552735 |
![]() 24620663 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
4 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.32 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 586.24 g/mol | |||
HBA | 6 | |||
HBD | 6 | |||
HBA + HBD | 12 | |||
AlogP | 9.88 | |||
TPSA | 121.38 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 4 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
19555126 | 12e | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 6.32 | |
19555126 | 12e | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 6.08 | |
19555126 | 12e | B2LA1 Q16548 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 5.30 | |
19555126 | 12e | B2CL1 Q07817 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 5.46 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7324 | Gossypol | DB13044 | |
0.5806 | 5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol | DB08466 | |
0.5385 | Masoprocol | DB00179 | |
0.5303 | Amylmetacresol | DB13908 | |
0.5211 | Xibornol | DB13714 | |
0.5082 | 2,5-di-tert-butylhydroquinone | DB04638 | |
0.5000 | Hexestrol | DB07931 | |
0.5000 | Hexylresorcinol | DB11254 | |
0.4921 | Biphenyl-2,3-Diol | DB02923 | |
0.4754 | t-Butylhydroquinone | DB07726 | |
0.4754 | Thymol | DB02513 | |
0.4737 | 5-PENTYL-2-PHENOXYPHENOL | DB07178 | |
0.4712 | Cannabivarin | DB14736 | |
0.4706 | Guaiazulen | DB13329 | |
0.4667 | Terameprocol | DB12226 |